Table 2 Generic introductions of antiretroviral drugs in the Netherlands, with lowest pharmacy purchase price (€)
Year | |||||||
|---|---|---|---|---|---|---|---|
2016 PPP** (€) | 2017 PPP** (€) | 2018 PPP** (€) | 2019 PPP** (€) | 2020 PPP** (€) | 2021 PPP** (€) | 2022 PPP** (€) | |
Antiretroviral substance | |||||||
Antivirals for treatment of HIV infections, combinations | |||||||
Abacavir/lamivudine (ABC/3TC) | 434.50 | 346.00 | 69.95 | 38.25 | 23.95 | 23.95 | 19.95 |
Tenofovir disoproxil/emtricitabine (TDF/FTC) | 526.56 | 378.52 | 47.50 | 28.12 | 28.12 | 28.12 | 28.12 |
Tenofovir disoproxil/emtricitabine/efavirenz (TDF/FTC/EFV) | 791.35 | 745.55 | 467.00 | 467.00 | 40.80 | 40.80 | 36.72 |
Protease inhibitors | |||||||
Atazanavir (ATZ) * | 436.79 | 427.47 | 423.01 | 408.32 | 385.50 | 254.19 | 254.10 |
Darunavir (DRV) * | 447.00 | 434.69 | 432.70 | 50.40 | 43.25 | 43.25 | 43.25 |
Ritonavir (RTV) | 342.79 | 25.58 | 21.62 | 21.62 | 21.62 | 21.62 | 21.62 |
Nucleoside and nucleotide reverse transcriptase inhibitors | |||||||
Abacavir (ABC) | 257.20 | 249.95 | 245.71 | 207.40 | 207.40 | 194.31 | 207.40 |
Tenofovir disoproxil (TDF) | 322.23 | 231.27 | 35.24 | 17.75 | 17.75 | 12.95 | 12.89 |
Non-nucleoside reverse transcriptase inhibitors | |||||||
Nevirapine (NVP) | 202.47 | 159.98 | 42.16 | 42.16 | 34.85 | 34.85 | 29.50 |